Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| LRP4 | O75096 | Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) | Disease related genesHuman disease related genesPotential drug targets | 1 | Congenital myasthenic syndrome | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.28 | ||
| LRP5 | O75197 | Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Osteogenesis imperfectaOsteopetrosisOsteoporosis | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.28 | ||
| LT4R1 | Q15722 | Leukotriene B4 receptor 1 (LTB4-R 1) (LTB4-R1) (Chemoattractant receptor-like 1) (G-protein coupled receptor 16) (P2Y purinoceptor 7) (P2Y7) | Essential proteinsG-protein coupled receptorsPredicted membrane proteins | 7 | Allergic/hypersensitivity disorderAsthmaCystic fibrosis | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.28 | ||
| LT4R2 | Q9NPC1 | Leukotriene B4 receptor 2 (LTB4-R 2) (LTB4-R2) (LTB4 receptor JULF2) (Leukotriene B4 receptor BLT2) (Seven transmembrane receptor BLTR2) | G-protein coupled receptorsPredicted membrane proteins | 7 | AsthmaHuman immunodeficiency virus diseaseIndeterminate colitis | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.28 | ||
| M3K7 | O43318 | Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) | Disease related genesEnzymesHuman disease related genes | Mature B-cell lymphoma | Clinical-translation mediationImmune mediationMetabolism mediation | 1 | 0.28 | |||
| M4K1 | Q92918 | Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1) | EnzymesPredicted intracellular proteins | Solid tumour/cancer | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.28 | |||
| MACF1 | Q9UPN3 | Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha) | Disease related genesHuman disease related genesPotential drug targets | Lissencephaly | Adhesion and uptake mediationReceptor-signaling mediation | 1 | 0.28 | |||
| NK1R | P25103 | Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Abnormal micturitionAcute diabetic complicationAcute upper respiratory infection | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.28 | ||
| NK2R | P21452 | Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2) | 7 | Abnormal micturitionAcute/chronic painAnxiety disorder | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.28 | |||
| SMO | Q99835 | Protein smoothened (Protein Gx) | Cancer-related genesDisease related genesFDA approved drug targets | 7 | Basal cell carcinomaBrain cancerChronic myelomonocytic leukaemia | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.28 |